Receptor-independent effects of endocannabinoids on ion channels

Current Pharmaceutical Design

Volumn 12, Issue 2, 2006, Pages 227-239

  Oz, Murat ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Arachidonic acid; Cannabinoids; Endocannabinoids; Fatty acids; Ion channels; Prostaglandins

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID; ACETYLSALICYLIC ACID; ALCOHOL; ANANDAMIDE; ANESTHETIC AGENT; ARACHIDONIC ACID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOL; CAPSAICIN; CAPSAZEPINE; CARBENOXOLONE; DRONABINOL; ENDOCANNABINOID; INDOMETACIN; ION CHANNEL; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR; RESINIFERATOXIN; RIMONABANT; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; WIN 552123; CANNABINOID RECEPTOR; LIGAND;

4 AMINOBUTYRIC ACID RELEASE; AMINO TERMINAL SEQUENCE; ANALGESIA; ANTIEMETIC ACTIVITY; BINDING COMPETITION; BRAIN CELL; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CHIMERA; CONCENTRATION RESPONSE; DOPAMINE UPTAKE; DRUG POTENCY; EVOKED RESPONSE; GAP JUNCTION; HIPPOCAMPUS; IC 50; IMMUNOMODULATION; IN VIVO STUDY; ION TRANSPORT; LIPID MEMBRANE; NERVE CELL; NERVE CELL GROWTH; NERVE CELL MEMBRANE POTENTIAL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SENSORY NERVE CELL; STEADY STATE; TRANSPORT KINETICS; TRIGEMINAL NERVE; ANIMAL; CHANNEL GATING; DRUG EFFECT; HUMAN;

ANIMALS; ENDOCANNABINOIDS; HUMANS; ION CHANNEL GATING; ION CHANNELS; LIGANDS; RECEPTORS, CANNABINOID;

EID: 33644843550     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206775193073     Document Type: Review

References (153)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561-4.
2. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61-5.
3. Matsuda LA. Molecular aspects of cannabinoid receptors. Crit Rev Neurobiol 1997; 11: 143-66.
4. Howlett AC, Mukhopadhyay S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 2000; 108:53-70.
5. McAllister SD, Glass M. CB(l) and CB(2) receptor-mediated signalling: a focus on endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 161-71.
6. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002; 54, 161-202.
7. Devane WA, Hamis L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946-9.
8. Mechoulam F, Fride E, Di Marzo V. Endocannabinoids. Eur J Pharmacol 1998; 359: 1-18.
9. De Petrocellis L, Cascio MG, Di Marzo V. The endocannabinoid system: a general view and latest additions. Br J Pharmacol 2004; 141: 765-74.
10. Shire D, Calandra B, Bouaboula M, Barth F, Rinaldi-Carmona M, Casellas P, el al. Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sci 1999; 65: 627-35.
11. Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 2002; 296: 678-82.
12. Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003; 83: 1017-66.
13. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 2003; 26: 184-92.
14. Kunos G, Jarai Z, Batkai S, Goparaju SK, Ishac EJ, Liu J, et al. Endocannabinoids as cardiovascular modulators. Chem Phys Lipids 2000; 108: 159-68
15. Fan P. Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. J Neurophysiol 1995; 73; 907-10.
16. 3 receptor-mediated ion current in Xenopus oocytes. Proc 3rd Eur Symp Drug Addiction & AIDS 1995; 3: 64.
17. Johnson DE, Heald SL, Daily RD, Janis RA. Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1, 4-dihydropyridine binding. Prostaglandins Leukot Essent Fatty Acids 1993; 48:429-37.
18. Shiamsue & Urushidani T, Hagiwara M, Nagao T. Effects of anandamide and arachidonic acid on specific binding of (+)- PN200-110, diltiazemn and (-)-desmethoxyveraparmil to L-type Ca2+ channel. Eur J Pharmacol 1996; 296: 347-50.
19. Oz M, Tchugunova Y, Dunn SMJ. Endogenous cannabinoid anandamide directly inhibits voltage-dependent calcium fluxes in rabbit T-tubule membrane preparations. Eur J Pharmacol 2000; 404: 13-20.
20. Jarrahian A, Hillard CJ. Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes. Prostaglandins Leukot Essent Fatty Acids 1997; 57: 551-4.
21. Chemin, J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 2000; 20: 7033-40.
22. Nicholson RA, Liao C, Zheng J, David LS, Coyne L, Errington AC, et al. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res 2003; 978: 194-204.
23. Poling JS, Rogawski MA, Salem N, Vicini S, Anandamide, an endogenous cannabinoid inhibits Shaker-related voltage-gated K+ channels. Neuropharmacology 1996; 35: 983-91.
24. Van den Bossche I, Vanheel B. influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. Br J Pharmacol 2000; 131: 85-93.
25. Maingret F, Patel AJ, Lazdunski M, Honore E. The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK- 1. EMBO J 2001; 20: 47-54.
26. Barann M, Molderings G, Bruss M, Bonisch H, Urban BW, Gothert M. Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol 2002; 137: 589-96.
27. 3 receptor-mediated responses in Xenopus oocytes. Synapse 2002; 46: 150-56.
28. 7 receptors expressed in Xenopus oocytes. Soc for Neurosci 1996; 22: 1522.
29. Oz M, Ravindran A, Zhang L, Morales M. Endogenous cannabinoid, anandamide inhibits neuronal nicotinic acethylcholine receptor-mediated responses in Xenopus oocytes. J Pharmacol Exp Ther 2003; 306: 1003-10.
30. Wiley JL, Martin BR. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. Chem Phys Lipids 2002; 121: 57-63.
31. Pertwee RG. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 1997; 74: 129-80.
32. Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 2002; 301: 1020-4.
33. Leggett JD, Aspley S, Beckett SR, D'Antona AM, Kendall DA, Kendall DA. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Br J Pharmacol 2004; 141: 253-62.
34. Fowler CJ. Oleamide: a member of the endocannabinoid family? Br J Pharmacol 2004; 141: 195-6.
35. Dunn SMJ, Bhat M, Oz M. The molecular structure and gating of calcium channels. Ion channels and Ion Transport. Editors, Foa, P., Walsh, M. Springer-Verlag, New York. 1994; pp: 1-18.
36. Xiao YF, Gomez AM, Morgan JP, Lederer WJ, Leaf A. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci USA 1997; 94: 4182-87.
37. Shimada T, Somlyo AP. Modulation of voltage-dependent Ca channel current by arachidonic acid and other long-chain fatty acids in rabbit intestinal smooth muscle. J Gen Physiol 1992; 100: 27-44.
38. Schmitt H, Meves H. Modulation of neuronal calcium by arachidonic acid and related substances. J Membr Biol 1995; 145: 233-44.
39. Vreugdenhil M, Bruehl C, Voskuyl RA, Kang JX, Leaf A, Wadman WJ. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci USA 1996; 93: 12559-63.
40. Vellani V, Reynolds AM, McNaughton PA. Modulation of the synaptic Ca2+ current in salamander photoreceptors by polyunsaturated fatty acids and retinoids. J Physiol 2000; 529: 333-44.
41. Van Der Stelt M, Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem 2004; 271: 1827-34.
42. Lo YK, Chiang HT, Wu SN. Effect of arvanil (N-arachidonoyl-vanillyl-amine), a nonpungent anandamide-capsaicin hybrid, on ion currents in NG108-15 neuronal cells. Biochem Phannacol 2003; 65: 581-91.
43. Docherty RJ, Yeats JC, Piper AS. Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture. Br J Pharmacol 1997; 121: 1461-7.
44. Kopanitsa MV, Panchenko VA, Magura EL, Lishko PV, Krishtal OA. Capsaicin blocks Ca2+ channels in isolated rat trigeminal and hippocampal neurones. Neuroreport 1995; 6: 2338-40.
45. Sim JH, Kim YC, Kim SJ, Lee SJ, Suh SH, Jun JY, et aL Capsaicin inhibits the voltage-operated calcium channels intracellularly in the antral circular myocytes of guinea-pig stomach. Life Sci 2001; 68: 2347-60.
46. Henry DJ, Chavkin C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neuroscience Lett 1995; 186: 91-94.
47. Chemin J, Nargeot J, Lory P. Neuronal T-type alpha-IH calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. J Neurosci 2002; 22: 6856-62.
48. Zhang Y, Cribbs LL, Satin J. Arachidonic acid modulation of alphaJH, a cloned human T-type calcium channel. Am J Physiol 2000; 278: H184-93.
49. Evans RM, Scott RH, Ross RA. Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br J Pharmacol 2004; 141: 1223-33.
50. Price TJ, Patwardhan A, Akopian AN, Hargreaves KM, Flores CM. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55, 212-2 on trigeminal sensory neurons. Br J Pharmacol 2004, 142: 257-66.
51. Shen M, Thayer SA. The cannabinoid agonist Win55, 212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res 1998; 783: 77-84.
52. Guo J, Ikeda SR. Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol Pharmacol 2004; 65: 665-74.
53. Turkanis SA, Partlow LM, Karler R. Delta-9-tetrahydrocannabinol depresses inward sodium current in mouse neuroblastoma cells. Neuropharmacology 1991; 30: 73-7.
54. Kumbaraci NM, Nastuk WL. Effects of delta 9-tetrahydrocannabinol on excitable membranes and neuromuscular transmission. Mol Pharmacol 1980; 17: 344-9.
55. Verdon B, Zheng J, Nicholson RA, Ganelli CR, Lees G. Stereoselective modulatory actions of oleamide on GABA(A) receptors and voltage-gated Na(+) channels in vitro: a putative endogenous ligand for depressant drug sites in CNS. Br J Pharmacol 2000; 129: 283-90.
56. Gulaya NM, Melnik AA, Balkov DI, Volkov GL, Vysotskiy MV, Vaskovsky VE. The effect of long-chain N-acylethanolamines on some membrane-associated functions of neuroblastorna C1300 N18 cells. Biochim Biophys Acta 1993; 1152: 280-88.
57. Kelley BG, Thayer SA. Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. Eur J Pharmacol 496: 33-39.
58. Fraser DD, Hoehn K, Weiss S, MacVicar BA. Arachidonic acid inhibits sodium currents and synaptic transmission in cultured striatal neurons. Neuron 1993; 11: 633-44.
59. Bendahhou S, Cummins TR, Agnew WS. Mechanism of modulation of the voltage-gated skeletal and cardiac muscle sodium channels by fatty acids. Am J Physiol 1997; 272: C592-600.
60. Seebungkert B, Lynch JW. Effects of polyunsaturated fatty acids on voltage-gated K+ and Na+ channels in rat olfactory receptor neurons. Eur J Neurosci 2002; 16: 2085-94.
61. Lee GY, Shin YK, Lee CS, Song JH. Effects of arachidonic acid on sodium currents in rat dorsal root ganglion neurons. Brain Res 2002; 950: 95-102.
62. Perrier JF, Alaburda A, Hounsgaard J. 5-HT1A receptors increase excitability of spinal motoneurons by inhibiting a TASK-1-like K+ current in the adult turtle. J Physiol 2003; 548: 485-92.
63. Fearon IM, Zhang M, Vollmer C, Nurse CA. GABA mediates autoreceptor feedback inhibition in the rat carotid body via presynaptic GABAB receptors and TASK-1. J Physiol 2003; 553: 83-94.
64. Gardener MJ, Johnson IT, Burnham MP, Edwards G, Heagerty AM, Weston AH. Functional evidence of a role for two-pore domain potassium channels in rat mesenteric and pulmonary arteries. Br J Pharmacol 2004; 142: 192-202.
65. Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ, Kempsill FE. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res 2003; 93: 957-64.
66. Barbuti A, Ishii S, Shimizu T, Robinson RB, Feinmark SJ. Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. Am J Physiol Heart Circ Physiol 2002; 282: H2024-30.
67. Oliver D, Lien CC, Soom M, Baukrowitz T, Jonas P, Fakler B. Functional conversion between A-type and delayed rectifier K+ channels by membrane lipids. Science 2004; 304: 265-70.
68. Hilgemann DW. Biochemistry. Oily barbarians breach ion channel gates. Science 2004; 304: 223-24.
69. Hilgemann DW, Feng S, Nasuhoglu C. The complex and intriguing lives of PIP2 with ion channels and transporters. Sci STKE 2001; 111: RE19.
70. Jackson MB, Yakel JL. The 5-HT3 receptor channel. Annu Rev Physiol 1995; 57: 447-68.
71. 3 receptor antagonists: a critical update on therapeutical potential. TIPS 1993; 14: 265-70.
72. Oz M, Zhang L, Spivak CE. Direct noncompetitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids. Arch Biochem Biophys 2002; 404: 293-301.
73. Hohmann AG, Herkenham M. Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience 1999; 90: 923-31.
74. Godlewski G, Gothert M, Malinowska B. Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT(3) receptor-mediated von Bezold-Jarisch reflex. Br J Pharmacol 2003; 138: 767-74.
75. Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F, Wells G. Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res 1996; 109: 125-37.
76. 7-nicotinic receptor-mediated currents in Xenopus oocytes. J Pharmacol Exp Ther 2004; 310: 1152-60.
77. Reeves DC, Lummis SC. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel. Mol Membr Biol 2002; 19:11-26.
78. Eisele JL, Bertrand S, Galzi JL, Devillers-Thiery A, Changeux JP, Bertrand D. Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities. Nature 1993; 366: 479-83.
79. 3 receptors expressed in Xenopus Oocytes. Brit J Pharmacol 1997; 120: 353-5.
80. Bouzat CB, Barrantes FJ. Effects of long-chain fatty acids on the channel activity of the nicotinic acetylcholine receptor. Receptors Channels 1993; 1: 251-8.
81. Nojima H, Sasaki T, Kimura I. Arachidonic acid and prostaglandin D2 cooperatively accelerate desensitization of nicotinic acetylcholine receptor channel in mouse skeletal muscles. Brain Res 2000; 852: 233-8.
82. Madden DR. The structure and function of glutamate receptor ion channels. Nat Rev Neurosci 2002; 3: 91 -101.
83. Hampson AJ, Bomheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, et al. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 1998; 70: 671-6.
84. Miller B, Sarantis M, Traynelis SF, Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992; 355: 722-5.
85. Akinshola BE, Taylor RE, Ogunsetian AB, Onaivi ES. Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol 1999; 360: 242-48.
86. Kovalchuk Y, Miller B, Sarantis M, Attwell D. Arachidonic acid depresses non-NMDA receptor currents. Brain Res 1994; 643: 287-95.
87. Wilding TJ, Chai YH, Huettner JE. Inhibition of rat neuronal kainate receptors by cis-unsaturated fatty acids. J Physiol 1998; 513: 331-9.
88. Montell C, Birnbaumer L, Flockerzi V, Bindels RJ, Bruford EA, Caterina MJ, et al. A unified nomenclature for the superfamily of TRP cation channels. Mol Cell 2002; 9: 229-31.
89. Hardie RC. Regulation of TRP channels via lipid second messengers. Annu Rev Pbysiol 2003; 65: 735-59.
90. Benham CD, Davis JB, Randall AD. Vanilloid and TRP channels: a family of lipid-gated cation channels. Neuropharmacology 2002; 42: 873-88.
91. Caterina MJ, Julius D. Sense and specificity: a molecular identity for nociceptors. Curr Opin Neurobiol 1999; 9: 525-30.
92. Zygmunt PM, Petersson J, Andersson, Chuang H, Sorgard M, Di Marzo V, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400: 452-7.
93. Piomelli D. The ligand that came from within. Trends Pharmacol Sci 2001; 22: 17-9.
94. Craib SJ, Ellington HC, Pertwee RG, Ross RA. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br J Pharmacol 2001; 134: 30-7.
95. Nilius B, Vriens J, Prenen J, Droogmans G, Voets T. TRPV4 calcium entry channel: a paradigm for gating diversity. Am J Physiol 2004; 286: C195-205.
96. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003; 424: 434-38.
97. Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Hogestatt ED, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTML Nature 2004; 427: 260-5.
98. Venance L, Piomelli D, Glowinski J, Giaume C. Inhibition by anandamide of gap junctions and intracellular calcium signaling in striatal astrocytes. Nature 1995; 376: 590-94.
99. Upham BL, Rummel AM, Carbone JM, Trosko JE, Ouyang Y, Crawford RB, et al. Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line. Int J Cancer 2003; 104: 12-8.
100. Moore H, Grace AA. A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies. Neuropsychopharmacology 2002; 27: 980-92.
101. Guan X, Cravatt BF, Ehring GR, Hall JE, Boger DL, Lerner RA, et al. The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells. Cell Biol 1997; 139: 1785-92
102. Lavado E, Sanchez-Abarca LI, Tabernero A, Bolanos JP, Medina JM. Oleic acid inhibits gap junction permeability and increases glucose uptake in cultured rat astrocytes. J Neurochem 1997; 69: 721-8.
103. Schmilinsky-Fluri G, Valiunas V, Willi M, Weingart R. Modulation of cardiac gap junctions: the mode of action of arachidonic acid. J Mol Cell Cardiol 1997; 29: 1703-13.
104. Malewicz B, Kumar VV, Johnson RG, Baumann WJ. Lipids in gap junction assembly and function. Lipids 1990; 25: 419-27.
105. Boger DL, Sato H, Lerner AE, Guan X, Gilula NB. Archidonic acid armide inhibitors of gap junction cell-cell communication. Bioorg Med Chem Lett 1999; 9: 1151-4.
106. Chen N, Appell M, Berfield JL, Reith ME. Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. Eur J Pharmacol 2003; 478: 89-95.
107. Steffens M, Feuerstein TJ. Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex-involvement of Na(+)/ K(+)-ATPase. Neurochem Int 2004; 44: 529-38.
108. Pearlman RJ, Aubrey KR, Vandenberg RJ. Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYTla. J Neurochem 2003; 84: 592-601.
109. Kimura T, Ohta T, Watanabe K, Yoshimura H, Yamamoto I. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. Biol Pharm Bull 1998; 21: 224-6.
110. Egashira N, Mishima K, Uchida T, Hasebe N, Nagai H, Mizuki A, et al. Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology (Berl) 2004; 171: 382-9.
111. Christopoulos A, Wilson K. Interaction of anandamide with the M(l) and M(4) muscarinic acetylcholine receptors. Brain Res 2001; 15: 70-8.
112. Lagalwar S, Bordayo EZ, Hoffmann KL, Fawcett JR, Frey WH. Anandamides inhibit binding to the muscarinic acetylcholine receptor. J Mol Neurosci 1999; 13: 55-61.
113. Biswas KK, M Sarker KP, Abeyama K, Kawahara K, Iino S, Otsubo Y, et al. Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. Hepatology 2003; 38: 1167-77.
114. Sarker KP, Maruyama I. Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. Cell Mol Life Sci 2003; 60: 1200-8.
115. Ordway RW, Singer JJ, Walsh JV Jr. Direct regulation of ion channels by fatty acids. Trends Neurosci 1991; 14: 96-100.
116. Meves, H. Modulation of ion channels by arachidonic acid. Prog. Neurobiol 1994; 43: 175-18.
117. Kogteva GS, Bezuglov VV. Unsaturated fatty acids as endogenous bioregulators. Biochemistry (Mosc) 1998; 63: 4-12.
118. Leaf A, Xiao YF, Kang JX. Interactions of n-3 fatty acids with ion channels in excitable tissues. Prostaglandins Leukot Essent Fatty Acids 2002; 67: 113-20.
119. Vijayaraghavan S, Huang B, Blumenthal EM, Berg DK. Arachidonic acid as a possible negative feedback inhibitor of nicotinic acetylcholine receptors on neurons. J Neurosci 1995; 15: 3679-3687.
120. Du C, Role LW. Differential modulation of nicotinic acetylcholine receptor subtypes and synaptic transmission in chick sympathetic ganglia by PGE2. J Neurophysiol 2001; 85: 2498-2508.
121. Bazan NG. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res 2003; 44: 2221-33.
122. Tillman TS, Cascio M. Effects of membrane lipids on ion channel structure and function. Cell Biochem Biophys 2003; 38: 161-90.
123. Valiyaveetil FI, Zhou Y, MacKinnon R. Lipids in the structure, folding, and function of the KcsA K+ channel. Biochemistry 2002; 41: 10771-7.
124. Lee SY, MacKinnon R. A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom. Nature 2004; 430: 232-5.
125. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367: 607-614.
126. Franks NP, Lieb WR. Mapping of general anaesthetic target sites provides a molecular basis for cutoff effects. Nature 1985; 316: 349-51.
127. Peoples RW, Chaoying L, Weight FF. Lipid vs protein theories of alcohol action in the nervous system. Ann Rev Pharmacol Toxicol 1996; 36: 185-201.
128. Yamakura T, Bertaccini E, Trudell JR, Harris RA. Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol 2001; 41: 23-51.
129. Rodriguez N, Villegas R, Requena J. The interaction of homologous series of alkanols with sodium channels in nerve membrane vesicles. J Membr Biol 1988; 104: 139-46.
130. 2+ channels. Eur J Pharmacol 1992; 229: 143-48.
131. Oz M, Tchugunova Y, Dunn SMJ. Direct inhibition of voltage-dependent calcium fluxes by ethanol and higher alcohols in rabbit T-tubule membrane preparations. Eur J Pharmacol 2001; 418: 169-76.
132. Oz M, Tchugunova Y, Dunn SMJ. The effects of isoflurane on voltage-dependent calcium fluxes in rabbit T-tubule membranes; comparison with alcohols. Arch Biochem Biophys 2002; 398: 275-83.
133. Covarrubias M, Vyas TB, Escobar L, Wei A. Alcohols inhibit a cloned potassium channel at a discrete saturable site. Insights into the molecular basis of general anesthesia. J Biol Chem 1995; 270: 19408-16.
134. Shabidullah M, Harris T, Germann MW, Covarrubias M. Molecular features of an alcohol binding site in a neuronal potassium channel. Biochemistry 2003; 42: 11243-52.
135. Chu B, Treistman SN. Modulation of two cloned potassium channels by 1-alkanols demonstrates different cutoffs. Alcohol Clin Exp Res 1997; 21: 1103-7.
136. Oz M, Tchugunova Y, Dinc M. Differential Effects of Endocannabinoids and Synthetic Cannabinoids on Voltage-Dependent Calcium Fluxes in Rabbit T-Tubule Membranes; Comparison With Fatty Acids. Eur J Pharmacol 2004; 502: 47-58.
137. Oz M, Alptekin A, Tchugunova Y, Dine M. Effects of saturated long-chain N-acylethanolamines Voltage-Dependent Calcium Fluxes in Rabbit T-Tubule Membranes. Arch Biochern Biophys 2005; 434: 344-351.
138. Nakahiro M, Arakawa O, Nishimura T, Narahashi T. Potentiation of GABA-induced Cl- current by a series of n-alcohols disappears at a cutoff point of a longer-chain n-alcohol in rat dorsal root ganglion neurons. Neurosci Lett 1996; 205: 127-30.
139. Akinshola BE. Straight-chain alcolhols exhibit a cutoff in potency for the inhibition of recombinant glutamate receptor subunits. Br J Pharmacol 2001; 133: 651-8
140. Peoples RW, Weight FF. Cutoff in potency implicates alcohol inhibition of N-methyl-D-aspartate receptors in alcohol intoxication. Proc Natl Acad Sci USA 1995; 92: 2825-9
141. Li C, Peoples RW, Weight FF. Alcohol action on a neuronal membrane receptor: evidence for a direct interaction with the receptor protein. Proc Natl Acad Sci USA 1994; 91: 8200-4.
142. Wick MJ, Mihic SJ, Ueno S, Mascia MF, Trudell JR, Brozowski SJ, et al. Mutations of gamma-aminobutyric acid and glycine receptors change alcohol cutoff. evidence for an alcohol receptor? Proc Natl Acad Sci USA 1998; 95: 6504-9.
143. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997; 389: 385-9.
144. Ren H, Honse Y, Peoples RW. A site of alcohol action in the fourth membrane-associated domain of the N-methyl-D-aspartate receptor. J Biol Chem 2003; 278: 48815-20
145. Mascia MP, Trudell JR, Harris RA. Specific binding sites for alcohols and anesthetics on ligand-gated ion channels. Proc Natl Acad Sci USA 2000; 97: 9305-10.
146. Witt MR, Poulsen CF, Lukensmejer B, Westh-Hansen SE, Nabekura J, Akaike N, et al. Structural requirements for the interaction of unsaturated free fatty acids with recombinant human GABAA receptor complexes. Ann N Y Acad Sci 1999; 868: 697-700.
147. Koenig JA, Martin IL. Effect of free fatty acids on GABAA receptor ligand binding. Biochem Pharmacol 1992; 44: 11-5.
148. Lee AG. Lipid-protein interactions in biological membranes: a structural perspective. Biochim Biophys Acta 2003; 1612: 1-40.
149. Lundbaek JA, Birn P, Girshman J, Hansen AJ, Andersen OS. Membrane stiffness and channel function. Biochemistry 1996; 35: 3825-30.
150. Andersen OS, Nielsen C, Maer AM, Lundbaek JA, Goulian M, Koeppe RE. Ion channels as tools to monitor lipid bilayer-membrane protein interactions: gramicidin channels as molecular force transducers. Methods Enzymol 1999; 294: 208-24.
151. Suchyna TM, Tape SE, Koeppe RE 2nd, Andersen OS, Sachs F, Gottlieb PA. Bilayer-dependent inhibition of mechanosensitive channels by neuroactive peptide enantiomers. Nature 2004; 430: 235-40.
152. Garcia ML. Ion channels: gate expectations. Nature 2004; 430:153-55.
153. Oz M, Spivak CE, Lupica CR. The solubilizing detergents, Tween 80 and Triton X-100 non-competitively inhibit α7-nicotinic acetylcholine receptor function in Xenopus oocytes. J Neurosci Meth 2004; 137: 167-73.